New York, New York--(Newsfile Corp. - April 20, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Plug Power Inc. ("Plug Power") (NASDAQ: PLUG) between November 9, 2020 and March 1, 2021. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Southern District of New York. To ...
Organisers want to ‘put streaming income back where it belongs – in the hands of artists’.
Clara Amfo will take over as the host of Radio 1’s Future Sounds programme.
The pop star says he will not sue, despite the "hatred" shown towards him in a recent episode.
Dublin, April 20, 2021 (GLOBE NEWSWIRE) -- The "Global Virtual Clinical Trials Market By Study Type, By Indication, By Region, Industry Analysis and Forecast, 2020 - 2026" report has been added to ResearchAndMarkets.com's offering. The Global Virtual Clinical Trials Market size is expected to reach $10 billion by 2026, rising at a market growth of 6.5% CAGR during the forecast period. Virtual Clinical Trials (VCTs) are also known as remote or decentralized trails, are a comparatively new but still underused technique of carrying out clinical research taking complete benefit of technologies like apps, online social interaction platforms, and electronic monitoring tools. The market is significantly driven by growth in R&D activities, the growing digitization in healthcare, and the adoption of telehealth. Moreover, advances in technology, collaborations between clinical research companies, biotechnology companies, and pharmaceutical and support initiatives from governments are expected to boost the market.Virtual clinical trials (VCT) abolish limitations presented by conventional clinical trials such as time-taking procedures and delay in recruitment of patients that has pushed the demand for the virtual clinical trial market. Additionally, advances in technology in healthcare infrastructure and partnerships between pharmaceutical, biotechnology, and clinical research companies are expected to propel the virtual clinical trials market development in the coming years. The rise in costs, combined with a higher rate of trail failures and an expansion in patient-centric trials, has resulted in a rise in demand to adopt technology in clinical trials. In fact, virtual clinical trials are expected to rise from high revenue to the highest revenue in the upcoming years. Still despite this development, for the majority of patients, getting clinical trials is still a difficult process, with enrollment and engagement presenting new challenges.By Study TypeBased on Study Type, the market is segmented into Interventional, Observational, and Expanded Access and Others. The market was dominated by the interventional segment and represented the highest share of revenue in 2019. The fast growth in the number of experiments to create unique medications for different diseases and the modernization of labs are boosting the growth of this segment. The COVID-19 pandemic has fueled the demand for trials and testing of different new vaccines and drugs to fight situations all around the world, as conventional techniques of clinical trials accompany the massive danger of infection in individuals.By IndicationBased on Indication, the market is segmented into Oncology, Cardiovascular, Immunology, Gastrointestinal, Respiratory, Endocrinology, Ophthalmology and Other Indications. The market was dominated by the oncology segment and represented the highest share of revenue in 2019. The segment is also expected to add to the highest share of the revenue of the market during the forecast period. This is credited to the growing instances of cancer on a worldwide scale and the growing number of oncology clinical trials. Patients of cancer are the most unprotected during the outbreak of COVID-19.By RegionBased on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. Europe represents the second-largest market share and is anticipated to observe promising growth opportunities in the next few years. Support from the government for R&D for the medicines and treatment for coming infectious diseases and chronic diseases, particularly in nations like Germany and U.K is a significant component boosting the growth of the regional market. Furthermore, the existence of leading players and benefits environment for carrying out clinical trials is another element anticipated to push the growth of the clinical trial market in Europe during the forecast period.The major strategies followed by the market participants are Product Launches and Partnerships. Based on the Analysis presented in the Cardinal matrix; Oracle Corporation is the major forerunner in the Virtual Clinical Trials Market. Companies such as IQVIA Holdings, Inc., Dassault Systemes SE, and Medpace Holdings, Inc., are some of the key innovators in the market.The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include IQVIA Holdings, Inc., ICON PLC, Laboratory Corporation of America Holdings (Covance, Inc.), Dassault Systemes SE (Medidata Solutions, Inc.), Oracle Corporation, Parexel International Corporation (Pamplona Capital Management), PRA Health Sciences, Inc. (KKR & Co., Inc.), Medpace Holdings, Inc., Medable, Inc. and Clinical Ink, Inc. (G.I. Partners). Unique Offerings Exhaustive coverageHighest number of market tables and figuresSubscription based model availableGuaranteed best priceAssured post sales research support with 10% customization free Key Topics Covered: Chapter 1. Market Scope & Methodology1.1 Market Definition1.2 Objectives1.3 Market Scope1.4 Segmentation1.4.1 Global Virtual Clinical Trials Market, by Study Type1.4.2 Global Virtual Clinical Trials Market, by Indication1.4.3 Global Virtual Clinical Trials Market, by Geography1.5 Methodology for the researchChapter 2. Market Overview2.1 Introduction2.1.1 Overview2.1.2 Market Composition2.2 Key Factors Impacting the Market2.2.1 Market Drivers2.2.2 Market RestraintsChapter 3. Competition Analysis - Global3.1 Cardinal Matrix3.2 Recent Industry Wide Strategic Developments3.2.1 Partnerships, Collaborations and Agreements3.2.2 Product Launches and Product Expansions3.2.3 Geographical Expansions3.2.4 Acquisition and Mergers3.3 Top Winning Strategies3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2017, Oct - 2020, Nov) Leading Players3.3.3 Key Strategic Move: (Product Launches and Product Expansions : 2018, Jun - 2020, Oct) Leading PlayersChapter 4. Global Virtual Clinical Trials Market by Study Type4.1 Global Interventional Market by Region4.2 Global Observational Market by Region4.3 Global Expanded Access Market by RegionChapter 5. Global Virtual Clinical Trials Market by Indication5.1 Global Oncology Market by Region5.2 Global Cardiovascular Market by Region5.3 Global Immunology Market by Region5.4 Global Gastrointestinal Market by Region5.5 Global Respiratory Market by Region5.6 Global Endocrinology Market by Region5.7 Global Ophthalmology Market by Region5.8 Global Other Indications Market by RegionChapter 6. Global Virtual Clinical Trials Market by Region6.1 North America Virtual Clinical Trials Market6.2 Europe Virtual Clinical Trials Market6.3 Asia Pacific Virtual Clinical Trials Market6.4 LAMEA Virtual Clinical Trials Market Chapter 7. Company Profiles7.1 IQVIA Holdings, Inc.7.1.1 Company Overview7.1.2 Financial Analysis7.1.3 Segmental and Regional Analysis7.1.4 Recent strategies and developments126.96.36.199 Partnerships, Collaborations, and Agreements188.8.131.52 Product Launches and Product Expansions7.2 ICON PLC7.2.1 Company Overview7.2.2 Financial Analysis7.2.3 Regional Analysis7.2.1 Recent strategies and developments184.108.40.206 Partnerships, Collaborations, and Agreements220.127.116.11 Product Launches and Product Expansions18.104.22.168 Acquisition and Mergers7.3 Laboratory Corporation of America Holdings (Covance, Inc.)7.3.1 Company Overview7.3.2 Financial Analysis7.3.3 Segmental and Regional Analysis7.3.4 Recent strategies and developments22.214.171.124 Product Launches and Product Expansions126.96.36.199 Acquisition and Mergers7.4 Dassault Systemes SE (Medidata Solutions, Inc.)7.4.1 Company Overview7.4.2 Financial Analysis7.4.3 Regional Analysis7.4.4 Research & Development Expense7.4.5 Recent strategies and developments188.8.131.52 Partnerships, Collaborations, and Agreements184.108.40.206 Product Launches and Product Expansions220.127.116.11 Acquisition and Mergers7.5 Oracle Corporation7.5.1 Company Overview7.5.2 Financial Analysis7.5.3 Segmental and Regional Analysis7.5.4 Research & Development Expense7.5.5 Recent strategies and developments18.104.22.168 Partnerships, Collaborations, and Agreements22.214.171.124 Product Launches and Product Expansions7.6 Parexel International Corporation (Pamplona Capital Management)7.6.1 Company Overview7.6.2 Recent strategies and developments126.96.36.199 Partnerships, Collaborations, and Agreements188.8.131.52 Product Launches and Product Expansions184.108.40.206 Geographical Expansions7.7 PRA Health Sciences, Inc. (KKR & Co., Inc.)7.7.1 Company Overview7.7.2 Financial Analysis7.7.3 Segmental Analysis7.7.4 Recent strategies and developments220.127.116.11 Partnerships, Collaborations, and Agreements18.104.22.168 Product Launches and Product Expansions7.8 Medpace Holdings, Inc.7.8.1 Company Overview7.8.2 Financial Analysis7.8.3 Recent strategies and developments22.214.171.124 Partnerships, Collaborations, and Agreements7.9 Medable, Inc.7.9.1 Company Overview7.9.2 Recent strategies and developments126.96.36.199 Partnerships, Collaborations, and Agreements188.8.131.52 Product Launches and Product Expansions7.10. Clinical Ink, Inc. (G.I. Partners)7.10.1 Company Overview7.10.2 Recent strategies and developments184.108.40.206 Partnerships, Collaborations, and AgreementsFor more information about this report visit https://www.researchandmarkets.com/r/562t4q CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Pubs, cafes and restaurants in England are open for customers seated outdoors.
The more volatile things have been for equities, the more enticing it's been to young and novice investors. Just take a closer look at the success of online investing app Robinhood. Robinhood, which is known for its commission-free trades and gifting of free shares of stock to new members, gained in the neighborhood of 3 million new users in 2020.
Enviva Partners, LP (NYSE: EVA) (the "Partnership," "we," or "our") today announced that it has amended and restated its senior secured revolving credit facility. The transaction closed on April 16, 2021.
China's Great Wall Motor aims to sell around 270,000 pickup trucks this year, up from 225,000 units last year, Cui Xiaohui, general manager of Great Wall's pickup truck unit said on Tuesday. Baoding-based Great Wall, the top pickup truck maker in China, also aims to sell over 500,000 of the vehicles a year in 2025, Cui said, adding that half of the sales in 2025 will be overseas.
After a gunman killed eight workers and himself at an Indianapolis FedEx center last week - the city's third mass shooting this year - the chief deputy coroner spoke of the toll the deaths had taken on her coworkers. John Fudenberg knows such strain all too well. In 2017, after a gunman killed 58 people at an outdoor music festival in Las Vegas, Fudenberg's staff at the Clark County Coroner's Office was responsible for telling families their loved ones were dead.
Wajid Khan passed away last year due to COVID complications.
Telos’ aviation channeling services offer increased efficiency and flexibility in credentialing operations at one of the ten busiest airports in the world.ASHBURN, Va., April 20, 2021 (GLOBE NEWSWIRE) -- Telos ® Corporation (NASDAQ: TLS), a leading provider of cyber, cloud and enterprise security solutions for the world’s most security-conscious organizations, today announced that the City of Charlotte has contracted with Telos to provide Transportation Security Administration (TSA)-approved Designated Aviation Channeling (DAC) services for processing worker background checks at Charlotte Douglas International Airport (CLT). Telos’ DAC services improve data integrity, increase the efficiency of credentialing operations and reduce costs. DAC services enable submissions of workers’ biographic and biometric data to conduct background checks for individuals working in secure areas of U.S. commercial airports. “The DAC services deployment at Charlotte Douglas International Airport is notable for its integration with CLT’s Identity Management System, enabling efficient biographic and biometric transmissions,” said Dawn E. Lucini, vice president of aviation security, Telos. “We have streamlined the TSA-required aviation worker background check process, while upholding the high security and customer service standards at CLT.” As an encrypted, web-based solution, Telos’ DAC services meet TSA and Department of Homeland Security (DHS) requirements for handling personally identifiable information and biometrics. The modular design supports each airport’s and air carrier’s needs, and users can perform multiple functions on one platform. “Telos is the recognized leader in assuring the identities of aviation workers with advanced biometric and enrollment solutions, evidenced by the growing roster of airports and airlines – 90 and counting – that currently use Telos DAC services,” said Lucini. “We are pleased to support the City of Charlotte and its world-class airport in their efforts to provide excellence in credentialing and vetting services, all while reducing costs and providing superior customer care and flexibility.” In February 2021, Telos also added Fresno Yosemite International Airport (FAT) to their customer list. FAT is the primary commercial airport serving the San Joaquin Valley and three national parks: Yosemite, Sequoia, and Kings Canyon. For more information about Telos Designated Aviation Channeling services, visit: www.aviationchanneling.com. About Telos CorporationTelos Corporation (NASDAQ: TLS) empowers and protects the world’s most security-conscious organizations with solutions for continuous security assurance of individuals, systems, and information. Telos’ offerings include cybersecurity solutions for IT risk management and information security; cloud security solutions to protect cloud-based assets and enable continuous compliance with industry and government security standards; and enterprise security solutions for identity and access management, secure mobility, organizational messaging, and network management and defense. The company serves military, intelligence and civilian agencies of the federal government, allied nations and commercial organizations around the world. Media:Mia WilcoxMerritt Group on behalf of Telos Corporationwilcox@merrittgrp.com (610) 564-6773 Investors:Brinlea JohnsonThe Blueshirt Group on behalf of Telos Corporationbrinlea@blueshirtgroup.com
DUBLIN, Ireland and BRIDGEWATER, N.J., April 20, 2021 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with members of Amarin senior management to discuss the company's first quarter 2021 financial results and provide an operational update on Thursday, April 29, 2021, at 7:30 a.m. ET. The conference call will follow the anticipated release of the company's financial results earlier that day. Conference Call and Webcast Information: Amarin will host a conference call April 29, 2021, at 7:30 a.m. ET to discuss this information. The conference call can be heard live on the investor relations section of the company's website at www.amarincorp.com, or via telephone by dialing 888-506-0062 within the United States, 973-528-0011 from outside the United States, and referencing conference ID 942273. A replay of the call will be made available for a period of two weeks following the conference call. To hear a replay of the call, dial 877-481-4010, PIN: 40926. A replay of the call will also be available through the company's website shortly after the call. To Ask Questions: During the teleconference, following prepared remarks, management will respond to questions from investors and analysts, subject to time limitations. Participants in the live teleconference will be provided an opportunity to ask questions. Investors may also e-mail their questions to firstname.lastname@example.org. Email questions will be accepted until Wednesday, April 28, 2021 at 4:00 p.m. ET. About Amarin Amarin is an innovative pharmaceutical company leading a new paradigm in cardiovascular disease management. From our scientific research foundation to our focus on clinical trials, and now our commercial expansion, we are evolving and growing rapidly. Amarin has offices in Bridgewater, New Jersey in the United States, Dublin in Ireland, and Zug in Switzerland as well as commercial partners and suppliers around the world. We are committed to rethinking cardiovascular risk through the advancement of scientific understanding of the impact on society of significant residual risk that exists beyond traditional therapies, such as statins for cholesterol management. Availability of Other Information About Amarin Investors and others should note that Amarin communicates with its investors and the public using the company website (www.amarincorp.com), the investor relations website (investor.amarincorp.com), including but not limited to investor presentations and investor FAQs, Securities and Exchange Commission filings, press releases, public conference calls and webcasts. The information that Amarin posts on these channels and websites could be deemed to be material information. As a result, Amarin encourages investors, the media, and others interested in Amarin to review the information that is posted on these channels, including the investor relations website, on a regular basis. This list of channels may be updated from time to time on Amarin’s investor relations website and may include social media channels. The contents of Amarin’s website or these channels, or any other website that may be accessed from its website or these channels, shall not be deemed incorporated by reference in any filing under the Securities Act of 1933. Amarin Contact Information Investor Inquiries:Investor RelationsAmarin Corporation plcIn U.S.: +1 (908) 719-1315 IR@amarincorp.com (investor inquiries) Solebury Troutamarinir@troutgroup.com Media Inquiries:CommunicationsAmarin Corporation plcIn U.S.: +1 (908) 892-2028 PR@amarincorp.com (media inquiries)
The "Business Survey 1Q 2021: the Impact of COVID-19 on SMBs' Cyber-Security Solutions Usage and Plans" report has been added to ResearchAndMarkets.com's offering.
Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focused on commercializing excimer laser systems to treat vascular and dermatological diseases, announces an increase in enrollment in its pivotal clinical trial to evaluate the safety and effectiveness of the DABRA excimer laser system as an atherectomy device for the treatment of peripheral arterial disease (PAD). A total of 42 subjects have been enrolled as of April 19, 2021.
South Africa’s captain apologised to stakeholders for the administrative crisis in Cricket South Africa (CSA).
KUALA LUMPUR, Malaysia — Malaysian opposition lawmakers led by former Prime Minister Mahathir Mohamad submitted a petition to the country’s king on Tuesday seeking an end to a coronavirus emergency so Parliament can resume. The king approved Prime Minister Muhyiddin Yassin’s plan for an emergency in early January to curb the spread of the coronavirus, but critics said it was a political ruse to help the embattled leader stay in power amid challenges to his leadership. The emergency involves no curfew or military powers but Parliament is suspended until Aug. 1. Muhyiddin’s government remains in control and has extraordinary powers to introduce laws without parliamentary approval. Mahathir, 95, accused Muhyiddin of using the king’s name as a shield against critics, making many Malays angry with the monarch instead. He told reporters outside the palace gate that he hopes the king will heed the people’s voices. More than 39,000 Malaysians have signed an online petition since March for the king to end the emergency. THE VIRUS OUTBREAK: — Learning to breathe: German clinic helps COVID-19 long haulers — Asian Americans wrestle with returning to classrooms amid rising harassment — Hungary’s poor Roma children struggle with digital education — Follow all of AP’s pandemic coverage at https://apnews.com/hub/coronavirus-pandemic and https://apnews.com/hub/coronavirus-vaccine ___ HERE’S WHAT ELSE IS HAPPENING: PRAGUE — The coronavirus pandemic has badly affected beer consumption in the Czech Republic. In the beer-loving nation, average consumption per person dropped by 7 litres (14.8 pints) to 135 litres (285 pints) last year. It’s the lowest amount since the 1960s, according to the Czech union of brewers. Frantisek Samal, the head of the union, said he has never experienced such a crisis. Up to 500 pubs have had to close permanently and hundreds more are expected to follow suit this year. Bars and restaurants were closed for many months after the pandemic hit the country in March last year. A ban on drinking alcohol in public and the cancellation of sports, cultural and other events also contributed to the drop. Overall beer production in the country was down by 6.9% at 20.1 million hectolitres (531 million gallons). Beer exports were down by 381,000 hectolitres to about 5 million hectolitres, the first decline after nine years of growth. The Czech Republic has been one of the hardest-hit European countries. The nation of 10.7 million has has reported over 1.6 million COVID-19 cases, including 28,640 deaths. ___ MEXICO CITY — For the first time in a year, Mexican school children have returned to classrooms — at least in the southern state of Campeche. The Gulf coast state has been the state least affected by the pandemic in Mexico, and it was the first to get its teachers vaccinated. So Campeche is the first, and so far the only, of Mexico’s 32 states to reopen its classrooms. While it may have been good to get back to school Monday, the scene in Campeche was different from before: Grade-school children were allowed back in small groups to maintain social distancing, and they wore face masks and plastic face shields. ___ WELLINGTON, New Zealand — The Pacific nation of Fiji has closed schools and cancelled sporting events as it deals with its first coronavirus infections outside quarantine cases in more than a year. A soldier and a room cleaner at a quarantine facility have both tested positive, but there hasn’t been any indication so far the virus is spreading more widely in the community. Prime Minister Frank Bainimarama says Fiji is again facing a “grave and present danger.” The government has ordered all gyms, bars and theatres within two containment zones closed and large gatherings across the nation cancelled for at least two weeks. Home to a little under 1 million people, Fiji has recorded just two COVID-19 deaths since the pandemic began, but experts fear its health system would be ill-equipped to deal with a major outbreak. The Associated Press
from 2021 to 2026. The growth of the automotive camera and integrated radar and camera market is majorly driven by increasing consumer demand for advanced security systems, rising demand for vehicle safety systems for premium segment vehicles, and increasing number of regulations mandating safety features in vehicles.New York, April 20, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Automotive Camera and Integrated Radar and Camera Market with COVID-19 Impact Analysis, by Type, Application, View Type, Vehicle Type And Geography – Global Forecast to 2026" - https://www.reportlinker.com/p06064436/?utm_source=GNW The pandemic has affected the growth of the automotive camera and integrated radar and camera industry since its emergence in early 2020.The automotive sector is facing heat amid a sharp decline in production and sales of vehicles.Continuous lockdown in several countries has affected cross-border trades, resulting in increased prices of raw materials.The prominent players across industries have been affected by this pandemic.The foreseeable decline in the growth of applications may have a considerable direct impact on the automotive camera and integrated radar and camera market.Integrated radar and camera expected to grow at the highest rate during the forecast period.The integrated radar and camera segment is expected to register a higher growth rate during the forecast market.It is currently a niche market.An integrated radar camera system includes camera and radar components housed in a single module.The module can be employed in a vehicle for safety applications such as ACC, forward collision warning (FCW), collision mitigation or avoidance via autonomous braking, and LDW.The integration of the camera and the radar into a single module results in a reduction in sensor costs.Additionally, camera and radar integration employ common or shared electronics and signal processing.With the increasing adoption of ADAS, the integrated radar and camera market is expected to witness significant growth in the coming years.ADAS application is expected to grow at the highest CAGR during the forecast period.The ADAS segment is projected to grow at a higher CAGR during the forecast period.Increasing awareness about vehicle safety ratings and decreasing component costs due to extensive adoption of cameras and radars will fuel the automotive camera and integrated radar and camera market for ADAS.Major OEMs are embracing ADAS solutions to achieve higher safety ratings to attract more consumers.Leading OEMs either standardize safety systems across models or offer them as additional features.Thus, the increasing penetration of ADAS features will boost the demand for components such as automotive cameras, integrated radar and camera systems, receivers, transmitters, and system-on-chip (SoC) during the forecast period. The market’s growth is driven by factors such as the rising adoption of ADAS in vehicles by different automobile OEMs, growing push through government mandates to introduce advanced safety features in vehicles, increasing level of vehicle autonomy, surging demand for safety features in vehicles by end users, and rising number of cameras adopted per vehicle.APAC is projected to grow at the highest CAGR during the forecast period.Automotive camera and integrated radar and camera market in APAC is expected to grow at the highest CAGR during 2020?2025.The latest technological breakthroughs have facilitated advancements in automotive cameras and integrated radar and camera systems that can make various processes in commercial and passenger vehicles more efficient and significantly enhance accuracy in various applications As a result, a number of manufacturers based in the region are investing in research and development activities for automotive camera and integrated radar and camera devices.APAC is leading region for passenger vehicle production, and rising adoption of cameras in vehicles for various applications is expected to drive the growth of market.Break-up of the profiles of primary participants:• By Company Type – Tier 1 – 40%, Tier 2 – 35%, and Tier 3 – 25%• By Designation – C-level Executives – 37%, Managers – 33%, and Others – 30%• By Region – Europe - 44%, North America – 33%, APAC – 18%, and RoW – 5%Aptiv PLC (Ireland), Nidec Corporation (Japan), Robert Bosch GmbH (Germany), Intel Corporation (US), Infineon Technologies AG (Germany), ZF Friedrichshafen (Germany), Continental AG (Germany), Valeo SA (France), Magna International (Canada), and Veoneer Inc. (Sweden) are some of the major players in automotive camera and integrated radar and camera marketAutomotive camera and integrated radar and camera market has been segmented into type, view type, vehicle type, application, and region. Automotive camera and integrated radar and camera market has been studied for North America, Europe, Asia Pacific (APAC), and the Rest of the World (RoW).Reasons to buy the report:• Illustrative segmentation, analysis, and forecast of the market based on type, view type, vehicle type, application, and region have been conducted to give an overall view of the automotive camera and integrated radar and camera market.• A value chain analysis has been performed to provide in-depth insights into the automotive camera and integrated radar and camera market ecosystem.• The report includes pricing analysis, patent analysis, ecosystem analysis as well as technology and case study analysis pertaining to automotive camera and integrated radar and camera.• The key drivers, restraints, opportunities, and challenges pertaining to the automotive camera and integrated radar and camera market have been detailed in this report.• Detailed information regarding the COVID-19 impact and related updates on the automotive camera and integrated radar and camera market has been provided in the report.• The report includes a detailed competitive landscape of the market, along with key players, as well as in-depth analysis of their revenues and market share.Read the full report: https://www.reportlinker.com/p06064436/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: email@example.com US: (339)-368-6001 Intl: +1 339-368-6001
University of Phoenix will sponsor the Arizona Hispanic Chamber of Commerce Buenos Dias Networking Webinar Thursday, April 29 2021, at 10 a.m. MDT discussing COVID-19’s impact on Arizona women.
Novocure (NASDAQ: NVCR) hasn't exactly been the kind of stock that fired up investors very much throughout most of 2021. In this Motley Fool Live video recorded on April 14, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss why investors are now really excited about Novocure. Keith Speights: Shares of Novocure, ticker there is NVCR, jumped 50% last Thursday.